EDGAR Filing Documents for 0001178913-24-001621

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001178913-24-001621

Filing Date

2024-05-08

Accepted

2024-05-08 07:05:07

Documents

Period of Report

2024-05-08

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	zk2431416.htm	6-K	13849
2	EXHIBIT 99.1	exhibit_99-1.htm	EX-99.1	10811
3		image0.jpg	GRAPHIC	70904
	Complete submission text file	0001178913-24-001621.txt		123635

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002

Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156

Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 24924203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)